APA
Suzaki Y., Uemura N., Takada M., Ohyama T., Itohda A., Morimoto T., Imai H., Hamasaki H., Inano A., Hosokawa M., Tateishi M. & Ohashi K. (20130613). The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans. : European journal of clinical pharmacology.
Chicago
Suzaki Yuki, Uemura Naoto, Takada Makoto, Ohyama Tetsuji, Itohda Akiko, Morimoto Takuya, Imai Hiromitsu, Hamasaki Hajime, Inano Akihiro, Hosokawa Masakiyo, Tateishi Masato and Ohashi Kyoichi. 20130613. The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans. : European journal of clinical pharmacology.
Harvard
Suzaki Y., Uemura N., Takada M., Ohyama T., Itohda A., Morimoto T., Imai H., Hamasaki H., Inano A., Hosokawa M., Tateishi M. and Ohashi K. (20130613). The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans. : European journal of clinical pharmacology.
MLA
Suzaki Yuki, Uemura Naoto, Takada Makoto, Ohyama Tetsuji, Itohda Akiko, Morimoto Takuya, Imai Hiromitsu, Hamasaki Hajime, Inano Akihiro, Hosokawa Masakiyo, Tateishi Masato and Ohashi Kyoichi. The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans. : European journal of clinical pharmacology. 20130613.